HomeBLTE • NASDAQ
add
Belite Bio Inc
Previous close
$56.60
Day range
$57.00 - $59.12
Year range
$31.01 - $86.20
Market cap
1.90B USD
Avg Volume
51.49K
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.46M | 64.73% |
Net income | -10.10M | -44.49% |
Net profit margin | — | — |
Earnings per share | -0.32 | -33.33% |
EBITDA | -11.42M | -64.95% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 145.15M | 64.65% |
Total assets | 152.13M | 60.74% |
Total liabilities | 6.31M | 49.87% |
Total equity | 145.82M | — |
Shares outstanding | 31.83M | — |
Price to book | 12.36 | — |
Return on assets | -21.38% | — |
Return on capital | -22.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.10M | -44.49% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2016
Website
Employees
25
